G
Glenn Thomas Horn
Researcher at Cetus Corporation
Publications - 33
Citations - 36563
Glenn Thomas Horn is an academic researcher from Cetus Corporation. The author has contributed to research in topics: Nucleic acid & Nucleic acid sequence. The author has an hindex of 16, co-authored 33 publications receiving 36001 citations. Previous affiliations of Glenn Thomas Horn include Hoffmann-La Roche.
Papers
More filters
Patent
Modification of DNA sequences
Glenn Thomas Horn,Michael Piatak +1 more
TL;DR: In this article, a vector DNA sequence with a restriction enzyme, removing any unwanted nucleotides, was decomposed with exonuclease III to create 5′ sticky ends, and the resulting mixture was treated with DNA polyemrase and ligase.
Book ChapterDOI
Analysis of Isotypic and Allotypic Sequence Variation in the HLA-DRβ Region Using the In Vitro Enzymatic Amplification of Specific DNA Segments
TL;DR: A previously unreported sequence, termed DRβX, is described and helps define one of the three major evolutionary groups of DR haplotypes.
Patent
Primers and probes for nucleic acid detection
TL;DR: In this paper, an oligonucleotide primer exhibiting complementarity to an end of a nucleic acid sequence corresponding to a second exon sequence in an HLA Class II gene was proposed.
Patent
Recombinant methods for the production of ricin a, ricin b, ricin or diphtheria toxin (dt)a or ab' fragment, suitable hosts and vectors therefor, and conjugates comprising ricin toxin a chain or diphtheria toxin
David H. Gelfand,Frances Cook Lawyer,Glenn Thomas Horn,Lawrence Greenfield,Danute E. Nitecki,Donald Kaplan,Michael Piatak +6 more
TL;DR: Recombinant methods for the production of Ricin A, Ricin B, and Ricin of Diphtheria toxin (DT)A or AB′ fragment are described together with suitable hosts and vectors as discussed by the authors.
Patent
Recombinant ricin fragments, vectors and transformed hosts expressing the same, the modification of DNA sequences, and isolation of mRNA
Glenn Thomas Horn,Michael Piatak +1 more
TL;DR: In this article, the coding sequence for ricin B was cloned, disposed in suitable expression vectors and produced free of components normally accompanying this peptide, and a novel means of reconstructing missing portions of coding sequence, and certain improvements in messenger RNA purification were disclosed.